A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

Stopped Terminated early in agreement with Health Authorities for feasibility reasons

Conditions

• Cardiovascular Events

Interventions

• DRUG: Aliskiren
• DRUG: Amlodipine
• DRUG: Hydrochlorothiazide (HCTZ)
• DRUG: Placebo for Aliskiren
• DRUG: Placebo for Amlodipine
• DRUG: Placebo for Hydrochlorothiazide (HCTZ)

Sponsor

Novartis Pharmaceuticals